Venmax Drugs & Pharmaceuticals Ltd is engaged in the business of IT & ITES servicesBusiness Overview: a) VDPL is focused on establishing chain of Medical Stores with a brand name Ananya Pharma under the Venmax Drugs & Pharma Ltd, with the backing support of Formulations plant (Suzichem Labs). Currently, it...
Venmax Drugs and Pharmaceuticals Ltd has announced a board meeting on a tribunal directive to convene and hold a meeting of its equity shareholders regarding the scheme of amalgamation involving the company. This shareholder meeting is a key step in advancing the amalgamation process, directly impacting the corporate structure and...
Submission of Annual Report for the Financial Year 2025-26 Pursuant to Regulation 34 and other relevant provisions of the SEBI (Listing Obligations & Disclosure Requirements), 2015.
The board approved the 37th AGM for Sep 26, 2026, via VC. Mr. Venkata Rao Sadhanala becomes MD (₹0.30 Cr p.a.). Mrs. Padmaja Kalyani Sadhanala and Mr. Revoor Ramachandra are appointed as Non-Executive Directors. All key changes await shareholder approval.
Venmax Drugs & Pharma has announced a board meeting on August 31, 2026. The board will review the FY25-26 Annual Report, finalize the 37th AGM details, and discuss director appointments/designation changes, pending shareholder approval.
Venmax Drugs & Pharmaceuticals Limited has published newspaper advertisements detailing its financial results for the quarter ended June 30, 2026. These advertisements appeared in "Financial Express" and "Nava Telangana," ensuring broad public dissemination. This action provides crucial access for shareholders and potential investors to the company's latest quarterly performance data....
